Natarajan Ranganathan

Author

Kibow Biotech (United States)

Also Known As

Natarajan Ranganathan, Ranganathan Natarajan

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Kibow Biotech (United States)SUNY Downstate Health Sciences University University of Toronto State University of New York Thomas Jefferson University

About

Natarajan Ranganathan is an author at Kibow Biotech (United States) specializing in probiotics, medicine, and microbiome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	562
2	Public Health	1	1	91
3	Immunology	1	1	245
4	Metabolism	1	1	91
5	Microbiology	1	1	245

Natarajan Ranganathan

Publications

Citations

H-Index

Page 1

	Year	Citations
Probiotics, Prebiotics, and Synbiotics: Gut and Beyond Usha Vyas, Natarajan Ranganathan Gastroenterology Research and Practice PrebioticsBioinformatics ToolsProbioticDysbiosisMicrobiota	2012	245
Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease Natarajan Ranganathan, Pari Ranganathan, Eli A. Friedman, Advances in Therapy NutritionProbioticUrologyRenal DiseaseRenal Function	2010	226
Randomized Controlled Trial of Strain-Specific Probiotic Formulation (Renadyl) in Dialysis Patients Natarajan Ranganathan, Bohdan Pechenyak, Usha Vyas, BioMed Research International	2014	144
Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada Natarajan Ranganathan, Eli A. Friedman, Paul Tam, Current Medical Research and Opinion	2009	132
Probiotic supplements prevented oxonic acid-induced hyperuricemia and renal damage Fernando E. García‐Arroyo, Guillermo Gonzaga, Itzel Muñoz-Jiménez, PLoS ONE NutritionDysbiosisProbioticsFecal MicrobiotaOxidative Stress	2018	91
In Vitro and In Vivo Assessment of Intraintestinal Bacteriotherapy in Chronic Kidney Disease Natarajan Ranganathan, Beena Patel, Pari Ranganathan, ASAIO Journal	2006	89
Probiotic Amelioration of Azotemia in 5/6th Nephrectomized Sprague-Dawley Rats Natarajan Ranganathan, Beena Patel, Pari Ranganathan, The Scientific World JOURNAL	2005	81
Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease Senthilkumar Preethy, Nobunao Ikewaki, Gary Levy, BMJ Open Gastroenterology	2022	22
Metabolic profiling of a chronic kidney disease cohort reveals metabolic phenotype more likely to benefit from a probiotic. Subodh J. Saggi, Kelly Mercier, Jessica Gooding, PubMed	2017	10

Page 1